Newer antidepressants inhibit hot flashes

Menopause

Volumn 13, Issue 4, 2006, Pages 546-548

  Loprinzi, Charles L ^a   Barton, Debra ^a   Rummans, Teresa ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESTROGEN; FLUOXETINE; MEGESTROL ACETATE; PAROXETINE; SERTRALINE; TAMOXIFEN; VENLAFAXINE;

AGITATION; ANXIETY DISORDER; BREAST CANCER; CANCER SURVIVOR; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; EDITORIAL; HEADACHE; HOT FLUSH; HUMAN; INSOMNIA; IRRITABILITY; LETHARGY; MALAISE; MOOD; MYALGIA; NAUSEA; PARESTHESIA; PROSTATE CANCER; SEXUAL DYSFUNCTION; SIDE EFFECT; VOMITING; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; SERTRALINE;

EID: 33746058224     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000227397.76063.e4     Document Type: Editorial

References (21)

1. Loprinzi CL, Pisansky TM, Fonseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998;16:2377-2381.
2. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17-22.
3. Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychology 1998;7:129-132.
4. Loprinzi CL, Kugler JW, Sloan JA, et al. Randomized phase III controlled trial of venlafaxine in the management of hot flashes. Lancet 2000;356:2059-2063.
5. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005;105:161-166.
6. Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-6930.
7. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827-2834.
8. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-1583.
9. Gordon PR, Kerwin JP, Green Boesen K, Senf J. Sertraline to treat hot flashes: a randomized, controlled, double-blind, crossover trial in a general population. Menopause 2006;13:568-575.
10. Kimmick GG, Lovato J, McQuellon R, Robinson E, Muss H. Randomized, double-blind, placebo-controlled, cross-over study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 2006;12:114-122.
11. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18-26.
12. Bezchlibnyk-Butler KZ, Jeffries JJ. Clinical Handbook of Psychotropic Drugs, 15th ed. Cambridge, MA: Hogrefe & Huber, 2003:2-42.
13. Pandya KJ, Roscoe J, Pajon E, et al. A preliminary report of a double blind placebo controlled trial of gabapentin for control of hot flashes in women with breast cancer. A University of Rochester Cancer Center CCOP study. Proc Am Soc Clin Oncol 2004;23:8015.
14. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-345.
15. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994;331:347-352.
16. Utian WH, Shoupe D, Bachmann G. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-1079.
17. Quella SK, Loprinzi CL, Sloan J, et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 1999;162:98-102.
18. Loprinzi CL, Barton DL, Carpenter LA, et al. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 2004;79:1247-1251.
19. Shafgat A, Titzer ML, Sweeney CJ, et al. A phase II study of venlafaxine for the treatment of hot flashes in men undergoing androgen deprivation for prostate cancer [Abstract 8148]. Proc Am Soc Clin Oncol 2003;23:762.
20. Loprinzi CL, Flynn PJ, Carpenter LA, et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005;8:924-930.
21. Perez DG, Loprinzi CL, Sloan J, Novotny, P, Barton, D, Christensen B. Pilot evaluation of bupropion for the treatment of hot flashes. J Palliat Med 2006;9:631-637.